Biotech

Warnex Obtains Extension for the Repayment of its Debentures

LAVAL, QUEBEC: ...

Mediatum Co-Founder to Speak at Boston Biotech Conference

CAMBRIDGE, MA: Christoph Boehringer Is Co-Founder of Global Life Sciences Executive Search Firm ...

FDA Schedules Meeting With Cellceutix on New Psoriasis Drug

BEVERLY, MA: ...

Threshold Pharmaceuticals Announces Presentation and Webcast at BioCentury Future Leaders Conference

SOUTH SAN FRANCISCO, CA: ...

Break-Through Invention for Treating Cancer -- Australian Biotech Company Completes Round 1 Funding

MELBOURNE, AUSTRALIA: ...

Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2012

TORONTO, ONTARIO: ...

Rosetta Genomics to Raise $1.38 Million in Registered Direct Offering

PHILADELPHIA, PA and REHOVOT, ISRAEL: ...

Lonza and Agennix Sign Development and Manufacturing Deal for Production of Talactoferrin

BASEL, SWITZERLAND and PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: Contract Covers the Commercial Production of Talactoferrin, an Oral Dendritic Cell Mediated Immunotherapy (DCMI) Under Investigation for the Treatment of Non-Small Cell Lung Cancer (NSCLC); Lonza Will ...

Mymetics Appoints Grant Pickering CEO and Christopher Henney Chairman

EPALINGES, SWITZERLAND: - Grant E. Pickering named President and CEO - Dr. Christopher Henney appointed Chairman of the Board of Directors - Election of new members to the Board of Directors ...

Stem Cell Therapeutics Corp. Provides Corporate Update

CALGARY, ALBERTA: ...